Inhibition of Glucose-Stimulated Activation of Extracellular Signal-Regulated Protein Kinases 1 and 2 by Epinephrine in Pancreatic -Cells

Inhibition of Glucose-Stimulated Activation of Extracellular Signal-Regulated Protein Kinases 1 and 2 by Epinephrine in Pancreatic -Cells

Tara Beers Gibson,Michael C. Lawrence,Craig J. Gibson,Colleen A. Vanderbilt,Kathleen McGlynn,Don Arnette,Wei Chen,Julie Collins,Bashoo Naziruddin,Marlon F. Levy,Barbara Ehrlich,Melanie Cobb;Tara Beers Gibson;Michael C. Lawrence;Craig J. Gibson;Colleen A. Vanderbilt;Kathleen McGlynn;Don Arnette;Wei Chen;Julie Collins;Bashoo Naziruddin;Marlon F. Levy;Barbara Ehrlich;Melanie Cobb;
Diabetes 2006 Vol. 55 pp. 1066-1073
186
cobb2006diabetesinhibition

Abstract

Glucose sensing is essential for the ability of pancreatic β-cells to produce insulin in sufficient quantities to maintain blood glucose within the normal range. Stress causes the release of adrenergic hormones that increase circulating glucose by promoting glucose production and inhibiting insulin release. We have shown that extracellular signal–regulated kinases 1 and 2 (ERK1/2) are responsive to glucose in pancreatic β-cells and that glucose activates ERK1/2 by mechanisms independent of insulin. Here we show that glucose-induced activation of ERK1/2 is inhibited by epinephrine through the α2-adrenergic receptor. Epinephrine and the selective α2-adrenergic agonist UK14304 reduced insulin secretion and glucose-stimulated ERK1/2 activation in a pertussis toxin–sensitive manner, implicating the α subunit of a Gi family member. α2-adrenergic agonists also reduced stimulation of ERK1/2 by glucagon-like peptide 1 and KCl, but not by phorbol ester or nerve growth factor. Our findings suggest that α2-adrenergic agonists act via a Gi family member on early steps in ERK1/2 activation, supporting the idea that ERK1/2 are regulated in a manner that reflects insulin demand.

Citation

ID: 267604
Ref Key: cobb2006diabetesinhibition
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
267604
Unique Identifier:
10.2337/diabetes.55.04.06.db05-1266
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet